Keyphrases
Randomized Clinical Trial
100%
Clinical Analysis
57%
Meta-analysis
49%
Systematic Meta-analysis
41%
Placebo
37%
Confidence Interval
33%
Randomized Trial
25%
Risk of Bias
18%
Serious Adverse Events
18%
All-cause Mortality
16%
Cochrane
15%
Risk Ratio
14%
Stable Coronary Artery Disease
14%
Alcoholic Liver Disease
13%
Adverse Events
13%
Treatment as Usual
13%
Randomized Controlled Trial
12%
Alcoholic Cirrhosis
12%
Chronic Hepatitis C
12%
Major Depressive Disorder
11%
Statistical Analysis Plan
11%
Clinical Trials
10%
Alcoholic
10%
Quality of Life
10%
Usual Care
10%
High Risk
10%
Beneficial Effects
10%
Attention Deficit Hyperactivity Disorder
10%
Intervention Effect
10%
Random Error
9%
Primary Biliary Cirrhosis
9%
Hepatobiliary
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Ribavirin
8%
Copenhagen
8%
Interferon-α (IFN-α)
7%
Liver Disease
7%
COVID-19
7%
Antioxidant Supplementation
7%
Type 2 Diabetic Patients
7%
Methylphenidate
7%
Randomized Placebo-controlled Trial
7%
Certainty of Evidence
6%
Testosterone
6%
MEDLINE
6%
Embase
6%
Cirrhosis
6%
Relative Risk
6%
Clarithromycin
6%
Metformin
6%
Medicine and Dentistry
Randomized Clinical Trial
61%
Sequential Analysis
39%
Meta-Analysis
31%
Systematic Review
31%
Systematic Review with Meta-Analysis
25%
Placebo
23%
Adverse Event
17%
Clinical Trial
13%
Quality of Life
9%
Disease
7%
Alcohol Liver Disease
7%
Randomized Controlled Trial
7%
Heart Rehabilitation
7%
Maturity Onset Diabetes of the Young
6%
Brain Injury
6%
Adolescent
6%
Liver Cirrhosis
6%
Patient with Type 2 Diabetes
5%
Glycon
5%
All Cause Mortality
5%
Ischemic Heart Disease
5%
Major Depressive Episode
5%
Atrial Fibrillation
5%
Primary Biliary Cirrhosis
5%
Antioxidant
5%
Prevalence
5%
near Infrared Spectroscopy
5%
Symptom
5%
